Integra LifeSciences Holdings Corporation holds an earnings call to discuss its results for the second quarter of 2026 and provide commentary on business performance and outlook. The available source material references the company’s official earnings call presentation and a separate call summary, indicating that both focus on the same quarterly reporting event. However, the provided excerpts do not include the specific financial figures (such as revenue, earnings, or guidance), segment performance details, or operational updates. As a result, the shared information that can be confirmed from the supplied content is limited to the fact that the company reports 2026 Q2 results via an earnings call and accompanying presentation and that a third-party outlet summarizes that call for readers. No additional agreed-upon metrics, margin figures, product performance, or forward-looking statements are included in the text provided here.